Kamran Alam

TSHA

Kamran Alam serves as CHIEF FINANCIAL OFFICER at Taysha Gene Therapies, Inc. (TSHA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

8 trades

$1.45M

Net Position

Net Seller

$1.45M

Companies Traded

TSHA

Active Period

Aug 2021 – Feb 2026

8 total trades

Most Recent

Sell TSHA

Feb 4, 2026 · $7.5K

Kamran Alam's Insider Trading at Taysha Gene Therapies, Inc. (TSHA)

Buys

0 · $0.00

Sells

8 · $1.45M

Total Shares Bought

Total Shares Sold

286,806

TSHA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 4, 2026	Sell	1,655	$4.52	$7.5K	0
Jan 23, 2026	Sell	102,817	$4.72	$485.0K	0
Aug 21, 2025	Sell	54,491	$2.85	$155.3K	0
Mar 11, 2025	Sell	29,843	$1.69	$50.4K	0
Aug 25, 2023	Sell	33,000	$2.33	$76.9K	258,042
Aug 24, 2022	Sell	3,325	$3.47	$11.5K	266,121
Aug 22, 2022	Sell	28,675	$3.70	$106.0K	290,645
Aug 20, 2021	Sell	33,000	$16.88	$557.0K	319,928

Related Insiders

Sukumar Nagendran

President and Head of R&D

TSHASell · Jan 23, 2026

Sean P. Nolan

Chief Executive Officer

TSHASell · Jan 23, 2026

Paul B Manning

10% Owner

TSHABuy · May 30, 2025

Explore More Insider Trading Data

TSHA Insider Trading Activity

View all insider trades at Taysha Gene Therapies, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity